Page last updated: 2024-11-01

omeprazole and Essential Polyarteritis

omeprazole has been researched along with Essential Polyarteritis in 2 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imaeda, H1
Ishii, H1
Goto, M1
Colin-Jones, D1

Reviews

1 review available for omeprazole and Essential Polyarteritis

ArticleYear
[Treatment of peptic ulcer related to rheumatic diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Histamine H2 Antagonists; Humans; Lu

2002

Other Studies

1 other study available for omeprazole and Essential Polyarteritis

ArticleYear
Safety of omeprazole and lansoprazole.
    Lancet (London, England), 1994, May-28, Volume: 343, Issue:8909

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dog Diseases; Dogs; Lansoprazol

1994